Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Strategies for Optimal HIV Treatment and Prevention: Answering the Questions on Switching ART With Virologic Suppression

Hear from expert faculty as they answer questions and discuss key considerations when determining whether and how to switch antiretroviral therapy in virologically suppressed individuals with HIV.
Tristan J. Barber, MA, MD, FRCP
Darcy Wooten, MD
Released: October 11, 2022

Information on this Educational Activity

Faculty

Tristan J. Barber, MA, MD, FRCP

Honorary Associate Professor
Institute for Global Health
University College London
Consultant in HIV Medicine
Ian Charleson Day Centre
Royal Free Hospital
London, United Kingdom

Tristan J. Barber, MA, MD, FRCP: consultant/advisor/speaker: Gilead Sciences, Merck, Roche, Theratechnologies, ViiV Healthcare; researcher: Roche, ViiV Healthcare; unrestricted educational grant holder: Gilead Sciences.
Darcy Wooten, MD

Associate Professor of Medicine
Division of Infectious Diseases and Global Public Health
Department of Medicine
University of California, San Diego
San Diego, California

Darcy Wooten, MD, has no relevant financial relationships to disclose.

Staff

Heli Desai, MSc
Heli Desai, MSc, has no relevant financial relationships to disclose.
Ian Murphy, PhD
Ian Murphy, PhD, has no relevant financial relationships to disclose.
Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant financial relationships to disclose.
Julie Skowronski, NP
Julie Skowronski, FNP-BC, has no relevant financial relationships to disclose.
Jessica Adams, PharmD, BCPS, AAHIVP

Scientific Director

Jessica Adams, PharmD, BCPS, has no relevant financial relationships to disclose.
Jenny Schulz, PhD

Director, Scientific Services

Jenny Schulz, PhD, has no relevant financial relationships to disclose.

Target Audience

This program is intended for physicians, registered nurses, pharmacists, nurse practitioners and physician associates/physician assistants, and other healthcare providers who care for persons with or at risk of HIV infection.

Goal

The goal of this activity is to deliver the interprofessional HIV management team sustained education that will improve their knowledge and competence in making care decisions that address the needs of their individual patients.

Program Medium

This program has been made available online.

Related Content

Get expert updates on ART safety and tolerability from fall conferences, from Clinical Care Options (CCO)

Eric K. Farmer, PharmD, BCPS, AAHIVP Darcy Wooten, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: January 24, 2023 Expired: January 23, 2024

European pioneers discuss the latest data and guideline recommendations for implementing LA ART into practice, from Clinical Care Options (CCO)

Celia Jonsson-Oldenbuettel, MD, PhD
Program Director
person default Tom Stephane De Wit, MD, PhD Eric Florence, MD, PhD Mireia SantaCreu Guerrero, MSN person default Laurence Slama, MD, PhD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: January 20, 2023 Expired: January 19, 2024

Dr Eric Florence discusses clinic adaptations to promote successful integration of long-acting injectables for HIV in this commentary from Clinical Care Options (CCO)

Eric Florence, MD, PhD Released: January 17, 2023

Slides on HIV ART management in complex clinical situations, including extensive previous treatment, from Clinical Care Options (CCO)

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Released: January 11, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings